Global Biosimilars Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025 (Q1 2019 Update)

Global Biosimilars Market

360iResearch predicts the global biosimilars market to grow from USD 6,738.15 million in 2018 to USD 31,872.68 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.86%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Scope of the Report:

The research report categorizes the biosimilars market to forecast the revenues and analyze the trends in each of the following segments:

  • Global Biosimilars Market, by Indication
    • Autoimmune Diseases
      • Blood Disorders
        • Chronic Diseases
          • Growth Hormone Deficiency
            • Infectious Diseases
              • Oncology
              • Global Biosimilars Market, by Manufacturing
                • Contract Manufacturing
                  • In-House Manufacturing
                  • Global Biosimilars Market, by Product
                    • Recombinant Glycosylated Proteins
                      • Erythropoietin (EPO)
                      • Follitropin
                      • Monoclonal Antibodies (MABS)
                    • Recombinant Non-Glycosylated Proteins
                      • Granulocyte Colony-Stimulating Factor (Filgrastim)
                      • Insulin
                      • Interferons
                      • Recombinant Human Growth Hormone (RHGH)
                    • Recombinant Peptides
                      • Calcitonin
                      • Glucagon
                  • Global Biosimilars Market, by Geography
                    • Americas
                      • United States
                      • Brazil
                      • Canada
                      • Mexico
                      • Argentina
                    • Europe, Middle East & Africa
                      • United Kingdom
                      • Germany
                      • France
                      • Saudi Arabia
                      • United Arab Emirates
                      • Italy
                      • Russia
                    • Asia-Pacific
                      • China
                      • Japan
                      • India
                      • Australia

                  Company Usability Profiles:

                  The biosimilars market research report provides the company usability profiles and analyze the business overview, business strategy, and business SWOT analysis of the following company:

                  • AMEGA Biotech S.A.
                  • Amgen Inc.
                  • Apotex Inc.
                  • Biocon Limited
                  • Biogen Inc.
                  • Biosidus S.A.
                  • Bioton S.A.
                  • Dr. Reddy's Laboratories Limited
                  • Innovent Biologics, Inc.
                  • JHL Biotech, Inc.
                  • LG Chem, Ltd.
                  • Merck Sharp & Dohme Corp.
                  • Mylan N.V.
                  • Pfizer Inc.
                  • Sandoz International GmbH

                  Report Highlights:

                  The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of biosimilars market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the biosimilars market that will impact the demand during the forecast period. Moreover, the competitive analysis of biosimilars market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview and business SWOT analysis of the key companies in the market.

                  Reasons to Buy:

                  The biosimilars market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the global biosimilars market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

                  • Evaluate the qualitative and quantitative aspects of the report and analyze the biosimilars market penetration with respect to industries and geographies.
                  • Evaluate the key vendors in the biosimilars market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
                  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the biosimilars market.

                  Available customizations:

                  With this detailed report, we offer one of the following free customization options to our respectable clients:

                  • Competitive Benchmarking
                    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances
                  • Company Profiling
                    • Detailed profiling of additional market players (upto 3 players)
                    • SWOT analysis of key players (up to 3 players)
                  • Product Analysis
                    • Product matrix gives a detailed comparison of the product portfolio of each company
                  • Preface
                    • Objectives of the Study
                    • Market Segmentation & Coverage
                    • Years Considered for the Study
                    • Currency & Pricing
                    • Stakeholders
                  • Research & Forecasting
                    • Research Methodology
                      • Research Instruments
                        • Secondary Instrument
                        • Primary Instrument
                      • Research Approaches
                        • Bottom-up Approach
                        • Top-down Approach
                      • Research Reliability & Validity
                      • Research Assumptions
                      • Vendor Inclusion Criteria
                    • Forecasting Methodology
                      • Methodology for Market Estimation & Forecasting
                      • Significance and Importance of the Market Estimation & Forecasting
                  • Executive Summary
                  • Premium Insight
                    • Market Connectivity
                    • Market Dynamics
                      • Drivers
                        • Growing pressure to reduce healthcare expenditure
                        • Growing demands of pharmaceutical drugs
                        • Expiration of major patents during the forecast period
                        • Supportive government initiative and awareness creating programmes in the developing economies
                        • Lower cost biosimilars drugs than original biologics
                      • Restraints
                        • Reluctance of physicians to prescribe biosimilars
                        • Unawareness among patients and preference for brand
                      • Opportunities
                        • New indications and patent expiry of biologic products
                        • Potential in emerging markets
                        • Emergence of bio-betters drugs
                      • Challenges
                        • Stringent regulatory requirements adversely affecting investment in biosimilars market
                        • High investment required for research and development
                    • Porter’s Five Forces Analysis
                      • Threat of New Entrants
                      • Threat of Substitutes
                      • Bargaining Power of Customers
                      • Bargaining Power of Suppliers
                      • Industry Rivalry
                    • Technical Development & Trends
                      • Clinical Development Plans
                    • Regulatory Submissions Timelines
                    • Clinical Bio Analytics and Technical Timelines and Related FTEs
                    • Drugs Loosing Patent: 2018-2022
                  • Market Data Feed
                    • Introduction
                    • Global Biosimilars Market, by Indication
                      • Autoimmune Diseases
                        • Blood Disorders
                          • Chronic Diseases
                            • Growth Hormone Deficiency
                              • Infectious Diseases
                                • Oncology
                                • Global Biosimilars Market, by Manufacturing
                                  • Contract Manufacturing
                                    • In-House Manufacturing
                                    • Global Biosimilars Market, by Product
                                      • Recombinant Glycosylated Proteins
                                        • Erythropoietin (EPO)
                                          • Follitropin
                                            • Monoclonal Antibodies (MABS)
                                              • Adalimumab
                                              • Infliximab
                                              • Rituximab
                                          • Recombinant Non-Glycosylated Proteins
                                            • Granulocyte Colony-Stimulating Factor (Filgrastim)
                                              • Insulin
                                                • Interferons
                                                  • Interferon-Alpha
                                                  • Interferon-Beta
                                                • Recombinant Human Growth Hormone (RHGH)
                                                • Recombinant Peptides
                                                  • Calcitonin
                                                    • Glucagon
                                                  • Global Biosimilars Market, by Geography
                                                • Americas Biosimilars Market
                                                  • Americas Biosimilars Market, by Country
                                                    • United States
                                                    • Brazil
                                                    • Canada
                                                    • Mexico
                                                    • Argentina
                                                  • Americas Biosimilars Market, by Indication
                                                  • Americas Biosimilars Market, by Manufacturing
                                                  • Americas Biosimilars Market, by Product
                                                • Europe, Middle East & Africa Biosimilars Market
                                                  • Europe, Middle East & Africa Biosimilars Market, by Country
                                                    • United Kingdom
                                                    • Germany
                                                    • France
                                                    • Saudi Arabia
                                                    • United Arab Emirates
                                                    • Italy
                                                    • Russia
                                                  • Europe, Middle East & Africa Biosimilars Market, by Indication
                                                  • Europe, Middle East & Africa Biosimilars Market, by Manufacturing
                                                  • Europe, Middle East & Africa Biosimilars Market, by Product
                                                • Asia-Pacific Biosimilars Market
                                                  • Asia-Pacific Biosimilars Market, by Country
                                                    • China
                                                    • Japan
                                                    • India
                                                    • Australia
                                                  • Asia-Pacific Biosimilars Market, by Indication
                                                  • Asia-Pacific Biosimilars Market, by Manufacturing
                                                  • Asia-Pacific Biosimilars Market, by Product
                                                • 360iResearch Competitive Strategic Window
                                                  • Introduction
                                                    • Leverage Zone
                                                    • Vantage Zone
                                                    • Speculative Zone
                                                    • Bottleneck Zone
                                                • Competitive Landscape
                                                  • 360iResearch FPNV Positioning Matrix
                                                    • Introduction
                                                    • 360iResearch Scores
                                                      • Forefront
                                                      • Pathfinders
                                                      • Niche
                                                      • Vital
                                                    • Business Strategy
                                                    • Product Satisfaction
                                                  • Market Vendor Ranking Analysis
                                                  • Competitive News Feed Analysis
                                                • Company Usability Profiles
                                                  • AMEGA Biotech S.A.
                                                  • Amgen Inc.
                                                  • Apotex Inc.
                                                  • Biocon Limited
                                                  • Biogen Inc.
                                                  • Biosidus S.A.
                                                  • Bioton S.A.
                                                  • Dr. Reddy's Laboratories Limited
                                                  • Innovent Biologics, Inc.
                                                  • JHL Biotech, Inc.
                                                  • LG Chem, Ltd.
                                                  • Merck Sharp & Dohme Corp.
                                                  • Mylan N.V.
                                                  • Pfizer Inc.
                                                  • Sandoz International GmbH
                                                • Appendix
                                                  • Top Reports
                                                  • Author Details

                                                List of Tables (24 Tables)

                                                • Global Biosimilars Market SIZE, 2017 - 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY Indication, 2017 - 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY Manufacturing, 2017 - 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY Product, 2017 - 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY GEOGRAPHY, 2017 - 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY COUNTRY, 2017 - 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY Indication, 2017 - 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY Manufacturing, 2017 - 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY Product, 2017 - 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY COUNTRY, 2017 - 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY Indication, 2017 - 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY Manufacturing, 2017 - 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY Product, 2017 - 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY COUNTRY, 2017 - 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY Indication, 2017 - 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY Manufacturing, 2017 - 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY Product, 2017 - 2025 (USD million)
                                                • 360IRESEARCH SCORES FOR FOREFRONT IN Biosimilars MARKET
                                                • 360IRESEARCH SCORES FOR PATHFINDERS IN Biosimilars MARKET
                                                • 360IRESEARCH SCORES FOR NICHE IN Biosimilars MARKET
                                                • 360IRESEARCH SCORES FOR VITAL IN Biosimilars MARKET
                                                • 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR Biosimilars MARKET
                                                • 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR Biosimilars MARKET
                                                • Global Biosimilars Market RANKING, BY VENDORS, 2018

                                                List of Figures (32 Figures)

                                                • Global Biosimilars Market: YEARS CONSIDERED FOR THE STUDY
                                                • Global Biosimilars Market: KEY RESEARCH METHODOLOGY
                                                • Global Biosimilars Market: KEY RESEARCH INSTRUMENTS
                                                • Global Biosimilars Market: KEY SECONDARY INSTRUMENT SOURCES
                                                • Global Biosimilars Market: KEY POTENTIAL RESPONDENTS
                                                • Global Biosimilars Market: KEY BREAKDOWN OF PRIMARY INSTRUMENT
                                                • Global Biosimilars Market: KEY RESEARCH APPROACHES
                                                • Global Biosimilars Market: KEY DATA TRIANGULATION
                                                • Global Biosimilars Market: KEY RESEARCH ASSUMPTIONS
                                                • Biosimilars MARKET: KEY MARKET CONNECTIVITY
                                                • Global Biosimilars Market SIZE, 2017 - 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY Indication, 2018 vs 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY Manufacturing, 2018 vs 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY Product, 2018 vs 2025 (USD million)
                                                • Global Biosimilars Market SIZE, BY GEOGRAPHY, 2018 (USD million)
                                                • Americas Biosimilars Market SIZE, BY COUNTRY, 2018 vs 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY Indication, 2018 vs 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY Manufacturing, 2018 vs 2025 (USD million)
                                                • Americas Biosimilars Market SIZE, BY Product, 2018 vs 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY COUNTRY, 2018 vs 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY Indication, 2018 vs 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY Manufacturing, 2018 vs 2025 (USD million)
                                                • Europe, Middle East & Africa Biosimilars Market SIZE, BY Product, 2018 vs 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY COUNTRY, 2018 vs 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY Indication, 2018 vs 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY Manufacturing, 2018 vs 2025 (USD million)
                                                • Asia-Pacific Biosimilars Market SIZE, BY Product, 2018 vs 2025 (USD million)
                                                • 360iResearch Competitive Strategic Window for Global Biosimilars Market, BY Indication, 2025
                                                • 360iResearch Competitive Strategic Window for Global Biosimilars Market, BY Manufacturing, 2025
                                                • 360iResearch Competitive Strategic Window for Global Biosimilars Market, BY Product, 2025
                                                • 360iResearch Competitive Strategic Window for Global Biosimilars Market, BY GEOGRAPHY, 2025
                                                • 360IRESEARCH FPNV POSITIONING MATRIX FOR Biosimilars MARKET
                                                Format Properties
                                                Enterprise User License The product is a PDF. This is an enterprise license, allowing all employees within your organization access to the product.
                                                Corporate User License The product is a PDF. This is a site license, allowing all users within a given geographical location of your organization access to the product.
                                                Single User License The product is a PDF. This is a single user license, allowing one specific user access to the product.
                                                Web Pack License The product is a Online. This is a single user license, allowing one specific user access to the product online.
                                                Data Pack License The product is a excel. This is a single user license, allowing one specific user access to the product.
                                                Question Can I purchase select sections from this product?
                                                Answer At the present time, 360iResearch sell publications in their entirety only.
                                                Question Is this product printable?
                                                Answer This product is printable, for use by the end-user only.
                                                Question Is there a sample available from this product?
                                                Answer Please contact us using the “Request Free Sample Report” button on the right hand side of this webpage to request a sample.
                                                Question What is the methodology for this product?
                                                Answer This product is based on an in-depth qualitative and quantitative analysis of various markets. Qualitative analysis includes various projection and sampling techniques, whereas quantitative analysis includes primary interviews, surveys, vendor briefings, and expert opinions. Based on research and technical insights, the analysts refine existing research methodologies to analyse the various aspects of the market.

                                                The analysts collect input from vendors and industry experts, and verify this information with databases, financial products, industry papers, and various other secondary sources. In addition, the impact of the global economic conditions and other macroeconomic indicators are considered to assess the market.

                                                The analysts adopt primary and secondary research to ascertain market size and vendor landscape. This information is obtained by a bottom-up and top-down approach, and by leveraging in-house market modelling tools. It is then corroborated with data obtained from various market participants and stakeholders such as vendors, service providers, distributors, re-sellers, and end-users across the value chain.
                                                Question Can my company be invoiced for this product?
                                                Answer Yes. Simply place your order, select wire transfer or PayPal as your payment method and an invoice will be emailed to you. Please note that we require payment to be received in full before your order can be dispatched.